AIMC Topic: Pharmacogenetics

Clear Filters Showing 21 to 30 of 62 articles

PharmGKB Tutorial for Pharmacogenomics of Drugs Potentially Used in the Context of COVID-19.

Clinical pharmacology and therapeutics
Pharmacogenomics (PGx) is a key area of precision medicine, which is already being implemented in some health systems and may help guide clinicians toward effective therapies for individual patients. Over the last 2 decades, the Pharmacogenomics Know...

Precision psychiatry in clinical practice.

International journal of psychiatry in clinical practice
The treatment of depression represents a major challenge for healthcare systems and choosing among the many available drugs without objective guidance criteria is an error-prone process. Recently, pharmacogenetic biomarkers entered in prescribing gui...

Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches.

International journal of molecular sciences
A growing body of evidence now suggests that precision psychiatry, an interdisciplinary field of psychiatry, precision medicine, and pharmacogenomics, serves as an indispensable foundation of medical practices by offering the accurate medication with...

PGxCorpus, a manually annotated corpus for pharmacogenomics.

Scientific data
Pharmacogenomics (PGx) studies how individual gene variations impact drug response phenotypes, which makes PGx-related knowledge a key component towards precision medicine. A significant part of the state-of-the-art knowledge in PGx is accumulated in...

PharmVar GeneFocus: CYP2D6.

Clinical pharmacology and therapeutics
The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the highly polymorphic human CYP2D6 gene locus. CYP2D6 genetic variation impacts the metabolism of numerous drugs and, thus, can impact drug efficacy and safety. This GeneFocu...

The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later.

Clinical pharmacology and therapeutics
In 2009, the Clinical Pharmacogenetics Implementation Consortium (CPIC, www.cpicpgx.org), a shared project between Pharmacogenomics Knowledge Base (PharmGKB, http://www.pharmgkb.org) and the National Institutes of Health (NIH), was created to provide...

PGxO and PGxLOD: a reconciliation of pharmacogenomic knowledge of various provenances, enabling further comparison.

BMC bioinformatics
BACKGROUND: Pharmacogenomics (PGx) studies how genomic variations impact variations in drug response phenotypes. Knowledge in pharmacogenomics is typically composed of units that have the form of ternary relationships gene variant - drug - adverse ev...

Contemporary pharmacogenetic assays in view of the PharmGKB database.

Pharmacogenomics
AIM: Six modern PGx assays were compared with the Pharmacogenomics Knowledge Base (PharmGKB) to determine the proportion of the currently known PGx genotypes that are assessed by these assays.